Results 41 to 50 of about 1,733,550 (183)
MANAGEMENT OF ASTHMA-COPD OVERLAP SYNDROME: CLINICAL PHARMACIST PERSPECTIVE [PDF]
Patients with asthma-COPD overlap have more severe symptoms than those with either asthma or COPD alone, experiencing more frequent and more severe exacerbations and more frequent hospitalizations.
Farrag, Rana, R. +2 more
doaj +1 more source
Introduction Bronchial asthma and chronic obstructive pulmonary disease (COPD) are airway diseases with different etiology and a different presentation. Sometimes, asthma and COPD are present within the same patient as asthma–COPD overlap syndrome (ACOS).
Eman Shebl, Hanaa A Moety
doaj +1 more source
Early life origins of the Asthma–COPD Overlap Syndrome? [PDF]
See related ...
Robert J. Hancox, Xian Zhang
openaire +2 more sources
The Human Biomarker Navigator integrates the disease continuum, biomarker dynamics, cross‐organ biomarker networks, biomarker classification, and technology‐driven paradigms. It maps how biomarkers link multi‐system physiology and pathology across the nervous, respiratory, endocrine, circulatory, immune, digestive, urinary, reproductive, and ...
Meng‐Yao Li +29 more
wiley +1 more source
Mortality from asthma and COPD in Australia [PDF]
This report provides information about mortality due to asthma and chronic obstructive pulmonary disease (COPD) in Australia, examining trends over time, seasonal variation, international comparison and variation by age, sex, remoteness, Indigenous ...
core
The Endothelial CXCR Family in Vascular Health and Disease
ABSTRACT Endothelial cells (ECs) form the dynamic interface between blood and tissue, serving as key regulators of vascular homeostasis, inflammation, and repair. Among the molecular systems governing endothelial behavior, the C‐X‐C motif chemokine receptor (CXCR) family—originally characterized in immunology for its roles in leukocyte trafficking and ...
Zhiming Wu +4 more
wiley +1 more source
This review systematically compares the size‐dependent toxicity of microplastics and nanoplastics in the intestine, liver, kidney, lung, and brain. Particle size determines bioavailability, barrier penetration, and injury mechanisms. Because of their small size and high surface reactivity, NPs readily cross the intestinal epithelium and blood–brain ...
Yixian Cheng +14 more
wiley +1 more source
Defining asthma–COPD overlap syndrome: a population-based study [PDF]
Asthma–chronic obstructive pulmonary disease (COPD) overlap syndrome (ACOS) seems an important clinical phenotype, but multiple definitions have been proposed. This study's objectives were to assess the effect of different ACOS definitions on prevalence, patient characteristics and exacerbations.5675 individuals aged 45–65 years, with 846 asthma/COPD ...
Bonten, T.N. +7 more
openaire +3 more sources
Potential of Ginkgo biloba Extract to Intervene in Chronic Inflammation‐Related Diseases
Chronic inflammation is a pathological mechanism underpinning many diseases. Ginkgo biloba extract (GBE) is well known for its anti‐inflammatory property. GBE and its active constituents have been shown to attenuate pro‐inflammatory cytokine production, suppress nuclear factor kappa B activation, restore redox homeostasis, and modulate disease‐relevant
Yipeng Lin +7 more
wiley +1 more source
Interstitial changes in asthma‐COPD overlap syndrome
AbstractIntroductionAsthma‐COPD overlap syndrome (ACOS) is the widely recognized syndrome of asthma and COPD coexisting together. Cigarette smoking is a known risk factor for ACOS and is reported to be associated with interstitial lung diseases (ILDs).
Sahoko, Chiba +7 more
openaire +2 more sources

